Cargando…
BRAF V600E and lymph node metastases in papillary thyroid cancer
OBJECTIVE: To evaluate the relationship between the BRAF V600E mutation in lymph node metastasis (LNM) and its invasive characteristics in papillary thyroid cancer (PTC). MATERIAL AND METHODS: A total of 373 PTC patients were enrolled in this study conducted at Zhujiang Hospital of Southern Medical...
Autores principales: | Chen, Pan, Pan, Liqin, Huang, Wensi, Feng, Huijuan, Ouyang, Wei, Wu, Juqing, Wang, Jing, Deng, Yuying, Luo, Jiaxin, Chen, Yanying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576641/ https://www.ncbi.nlm.nih.gov/pubmed/33064665 http://dx.doi.org/10.1530/EC-20-0420 |
Ejemplares similares
-
Clinical significance of the BRAF(V600E) mutation in PTC and its effect on radioiodine therapy
por: Zhu, Guoquan, et al.
Publicado: (2019) -
Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAF(V600E) Mutation and Clinicopathological Features
por: Li, Gui-you, et al.
Publicado: (2020) -
Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases
por: Xie, Jiahao, et al.
Publicado: (2023) -
Locoregional progression-free survival of bone metastases from differentiated thyroid cancer
por: Luo, Jiaxin, et al.
Publicado: (2022) -
Corrigendum: Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases
por: Xie, Jiahao, et al.
Publicado: (2023)